dc.contributor.author | Ozdemir, Samet | |
dc.contributor.author | Uner, Melike | |
dc.contributor.author | Demirkoz, Asli Barla | |
dc.contributor.author | Celik, Burak | |
dc.date.accessioned | 2021-03-04T07:51:35Z | |
dc.date.available | 2021-03-04T07:51:35Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Celik B., Ozdemir S., Demirkoz A. B. , Uner M., "Optimization of piribedil mucoadhesive tablets for efficient therapy of Parkinson's disease: physical characterization and ex vivo drug permeation through buccal mucosa", DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, cilt.43, sa.11, ss.1836-1845, 2017 | |
dc.identifier.issn | 0363-9045 | |
dc.identifier.other | av_60461227-82f6-4858-96b3-1293144af8bd | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/67200 | |
dc.identifier.uri | https://doi.org/10.1080/03639045.2017.1349785 | |
dc.description.abstract | Objective: The aim of this study was optimization of buccal piribedil (PR) mucoadhesive tablets to improve its low bioavailability and provide controlled release for the treatment of Parkinson's disease. | |
dc.language.iso | eng | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Biyokimya | |
dc.subject | Temel Bilimler | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Eczacılık | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Temel Bilimler (SCI) | |
dc.subject | Kimya | |
dc.subject | KİMYA, TIP | |
dc.title | Optimization of piribedil mucoadhesive tablets for efficient therapy of Parkinson's disease: physical characterization and ex vivo drug permeation through buccal mucosa | |
dc.type | Makale | |
dc.relation.journal | DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | |
dc.contributor.department | Bezmiâlem Vakıf Üniversitesi , , | |
dc.identifier.volume | 43 | |
dc.identifier.issue | 11 | |
dc.identifier.startpage | 1836 | |
dc.identifier.endpage | 1845 | |
dc.contributor.firstauthorID | 239517 | |